Pharma Artios Appoints Michael T. Andriole as CEO and Director to Advance Alnodesertib (ART0380) into Late-stage Development 12 August 2026 | Press release
Pharma Artios Reports Differentiated Clinical Activity in STELLA Phase 1/2a Study for Lead Program ART0380 at the American Association for Cancer Research (AACR) Annual Meeting 2026 29 April 2026 | Press release
Pharma Artios Announces Details of Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2026 15 April 2026 | Press release
Pharma Artios to Present at the 43rd Annual J.P. Morgan Healthcare Conference 19 December 2024 | Press release
Pharma Artios Bolsters Board of Directors with Appointment of Chris Liu, PhD 9 April 2024 | Press release
Pharma Artios Strengthens Financial Leadership with Appointment of Christine Silverstein as Chief Financial Officer 7 February 2024 | Press release